Skip to main content
Erschienen in: Clinical Research in Cardiology 11/2011

01.11.2011 | Original Paper

Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry

verfasst von: Giuseppe Biondi-Zoccai, Imad Sheiban, Enrico Romagnoli, Stefano De Servi, Corrado Tamburino, Antonio Colombo, Francesco Burzotta, Patrizia Presbitero, Leonardo Bolognese, Leonardo Paloscia, Paolo Rubino, Gennaro Sardella, Carlo Briguori, Luigi Niccoli, Gianfranco Franco, Domenico Di Girolamo, Luigi Piatti, Cesare Greco, Davide Capodanno, Giuseppe Sangiorgi

Erschienen in: Clinical Research in Cardiology | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Coronary bifurcations remain a challenging lesion subset for percutaneous coronary intervention (PCI). It is unclear whether intravascular ultrasound (IVUS) guidance can improve PCI results in bifurcations. We aimed to compare IVUS-guided PCI versus standard PCI in a large registry of patients undergoing PCI for bifurcations in the drug-eluting stent era.

Methods

A multicenter, retrospective study was conducted enrolling consecutive patients undergoing bifurcation PCI between January 2002 and December 2006 at 22 centers. The primary end-point was the long term rate of major adverse cardiac events [MACE, i.e. death, myocardial infarction or target lesion revascularization (TLR)].

Results

A total of 4,314 patients were included, 226 (5.2%) undergoing IVUS-guided PCI, and 4,088 (94.8%) standard PCI. Early (30-day) outcomes were similar in the two groups, with MACE in 1.3 versus 2.1%, respectively, death in 0.9 versus 1.0%, and stent thrombosis in 0 versus 0.6% (all p > 0.05). After 24 ± 15 months, unadjusted rates of MACE were 17.7 versus 16.4%, with death in 2.7 versus 4.9%, myocardial infarction in 4.4 versus 3.7%, TLR in 15.0 versus 12.3%, and stent thrombosis in 3.1 versus 2.7% (all p > 0.05). Even at multivariable Cox proportional hazard analysis with propensity score adjustment, IVUS was not associated with any statistically significant impact on the risk of MACE, death, myocardial infarction, TLR (neither on the main branch nor on the side branch), or stent thrombosis (all p > 0.05).

Conclusions

Despite a sound rationale to choose stent size, optimize stent expansion and guide kissing inflation, IVUS usage during PCI for coronary bifurcation lesions was not associated with significant clinical benefits in this large retrospective study.
Literatur
1.
Zurück zum Zitat Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS, COURAGE trial research group (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503–1516PubMedCrossRef Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS, COURAGE trial research group (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503–1516PubMedCrossRef
2.
Zurück zum Zitat Al Suwaidi J, Yeh W, Cohen HA, Detre KM, Williams DO, Holmes DR Jr (2001) Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). Am J Cardiol 87:1139–1144PubMedCrossRef Al Suwaidi J, Yeh W, Cohen HA, Detre KM, Williams DO, Holmes DR Jr (2001) Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). Am J Cardiol 87:1139–1144PubMedCrossRef
3.
Zurück zum Zitat Hoffmann R, Klinker H, Adamu U, Kelm M, Blindt R (2009) The risk of definitive stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use. Clin Res Cardiol 98:549–554PubMedCrossRef Hoffmann R, Klinker H, Adamu U, Kelm M, Blindt R (2009) The risk of definitive stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use. Clin Res Cardiol 98:549–554PubMedCrossRef
4.
Zurück zum Zitat Capodanno D, Capranzano P, Bucalo R, Sanfilippo A, Ruperto C, Caggegi A, Ussia G, Galassi AR, Tamburino C (2009) A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score. Clin Res Cardiol 98:240–248PubMedCrossRef Capodanno D, Capranzano P, Bucalo R, Sanfilippo A, Ruperto C, Caggegi A, Ussia G, Galassi AR, Tamburino C (2009) A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score. Clin Res Cardiol 98:240–248PubMedCrossRef
5.
Zurück zum Zitat Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370:937–948PubMedCrossRef Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370:937–948PubMedCrossRef
6.
Zurück zum Zitat Colombo F, Biondi-Zoccai G, Infantino V, Omedé P, Moretti C, Sciuto F, Siliquini R, Chiadò S, Trevi GP, Sheiban I (2009) A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions. Acta Cardiol 64:583–588PubMedCrossRef Colombo F, Biondi-Zoccai G, Infantino V, Omedé P, Moretti C, Sciuto F, Siliquini R, Chiadò S, Trevi GP, Sheiban I (2009) A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions. Acta Cardiol 64:583–588PubMedCrossRef
7.
Zurück zum Zitat Qasim A, Cosgrave J, Latib A, Colombo A (2007) Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications. Am J Cardiol 100:1619–1624PubMedCrossRef Qasim A, Cosgrave J, Latib A, Colombo A (2007) Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications. Am J Cardiol 100:1619–1624PubMedCrossRef
8.
Zurück zum Zitat Garrone P, Biondi-Zoccai G, Salvetti I, Sina N, Sheiban I, Stella PR, Agostoni P (2009) Quantitative coronary angiography in the current era: principles and applications. J Interv Cardiol 22:527–536PubMedCrossRef Garrone P, Biondi-Zoccai G, Salvetti I, Sina N, Sheiban I, Stella PR, Agostoni P (2009) Quantitative coronary angiography in the current era: principles and applications. J Interv Cardiol 22:527–536PubMedCrossRef
9.
Zurück zum Zitat Biondi-Zoccai GG, Giraudi E, Moretti C, Sciuto F, Omedè P, Sillano D, Garrone P, Trevi GP, Sheiban I (2010) Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry. Clin Res Cardiol 99:235–242PubMedCrossRef Biondi-Zoccai GG, Giraudi E, Moretti C, Sciuto F, Omedè P, Sillano D, Garrone P, Trevi GP, Sheiban I (2010) Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry. Clin Res Cardiol 99:235–242PubMedCrossRef
10.
Zurück zum Zitat Mudra H, di Mario C, de Jaegere P, Figulla HR, Macaya C, Zahn R, Wennerblom B, Rutsch W, Voudris V, Regar E, Henneke KH, Schächinger V, Zeiher A, OPTICUS (OPTimization with ICUS to reduce stent restenosis) study investigators (2001) Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study). Circulation 104:1343–1349PubMedCrossRef Mudra H, di Mario C, de Jaegere P, Figulla HR, Macaya C, Zahn R, Wennerblom B, Rutsch W, Voudris V, Regar E, Henneke KH, Schächinger V, Zeiher A, OPTICUS (OPTimization with ICUS to reduce stent restenosis) study investigators (2001) Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study). Circulation 104:1343–1349PubMedCrossRef
11.
Zurück zum Zitat Casella G, Klauss V, Ottani F, Siebert U, Sangiorgio P, Bracchetti D (2003) Impact of intravascular ultrasound-guided stenting on long-term clinical outcome: a meta-analysis of available studies comparing intravascular ultrasound-guided and angiographically guided stenting. Catheter Cardiovasc Interv 59:314–321PubMedCrossRef Casella G, Klauss V, Ottani F, Siebert U, Sangiorgio P, Bracchetti D (2003) Impact of intravascular ultrasound-guided stenting on long-term clinical outcome: a meta-analysis of available studies comparing intravascular ultrasound-guided and angiographically guided stenting. Catheter Cardiovasc Interv 59:314–321PubMedCrossRef
12.
Zurück zum Zitat Russo RJ, Silva PD, Teirstein PS, Attubato MJ, Davidson CJ, DeFranco AC, Fitzgerald PJ, Goldberg SL, Hermiller JB, Leon MB, Ling FS, Lucisano JE, Schatz RA, Wong SC, Weissman NJ, Zientek DM (2009) AVID Investigators. A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial). Circ Cardiovasc Interv 2:113–123PubMedCrossRef Russo RJ, Silva PD, Teirstein PS, Attubato MJ, Davidson CJ, DeFranco AC, Fitzgerald PJ, Goldberg SL, Hermiller JB, Leon MB, Ling FS, Lucisano JE, Schatz RA, Wong SC, Weissman NJ, Zientek DM (2009) AVID Investigators. A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial). Circ Cardiovasc Interv 2:113–123PubMedCrossRef
13.
Zurück zum Zitat Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Weissman NJ, Lindsay J, Waksman R (2008) The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 29:1851–1857PubMedCrossRef Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Weissman NJ, Lindsay J, Waksman R (2008) The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 29:1851–1857PubMedCrossRef
14.
Zurück zum Zitat Costantini CO, Tarbine SG, Santos MF, Bubna M, Medeiros MA, Barbosa M, Duarte E, Denk MA, Sipraki R, Costantini CR (2008) Impact of intravascular ultrasound to guide drug eluting stent implantation decreasing long term clinical events. Am J Cardiol 102:161i Costantini CO, Tarbine SG, Santos MF, Bubna M, Medeiros MA, Barbosa M, Duarte E, Denk MA, Sipraki R, Costantini CR (2008) Impact of intravascular ultrasound to guide drug eluting stent implantation decreasing long term clinical events. Am J Cardiol 102:161i
15.
Zurück zum Zitat Agostoni P, Valgimigli M, Van Mieghem CAG, Rodriguez-Granillo GA, Aoki J, Ong ATL, Tsuchida K, McFadden EP, Ligthart JM, Smits PC, de Jaegere P, Sianos G, Van der Giessen WJ, De Feyter P, Serruys PW (2005) Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am J Cardiol 95:644–647PubMedCrossRef Agostoni P, Valgimigli M, Van Mieghem CAG, Rodriguez-Granillo GA, Aoki J, Ong ATL, Tsuchida K, McFadden EP, Ligthart JM, Smits PC, de Jaegere P, Sianos G, Van der Giessen WJ, De Feyter P, Serruys PW (2005) Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am J Cardiol 95:644–647PubMedCrossRef
16.
Zurück zum Zitat Park SJ, Kim YH, Park DW, Lee SW, Kim WJ, Suh J, Yun SC, Lee CW, Hong MK, Lee JH, Park SW, MAIN-COMPARE investigators (2009) Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv 2:167–177PubMedCrossRef Park SJ, Kim YH, Park DW, Lee SW, Kim WJ, Suh J, Yun SC, Lee CW, Hong MK, Lee JH, Park SW, MAIN-COMPARE investigators (2009) Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv 2:167–177PubMedCrossRef
17.
Zurück zum Zitat Kim SH, Kim YH, Kang SJ, Park DW, Lee SW, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ (2010) Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions. Am J Cardiol 106:612–618PubMedCrossRef Kim SH, Kim YH, Kang SJ, Park DW, Lee SW, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ (2010) Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions. Am J Cardiol 106:612–618PubMedCrossRef
18.
Zurück zum Zitat Romagnoli E, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Ettori F, Franco G, Di Girolamo D, Sheiban I, Piatti L, Greco C, Petronio S, Loi B, Lioy E, Benassi A, Patti A, Gaspardone A, Capodanno D, Biondi-Zoccai GG, Sangiorgi G, I-BIGIS study group (2010) Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS). Am Heart J 160:535–542.e1PubMedCrossRef Romagnoli E, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Ettori F, Franco G, Di Girolamo D, Sheiban I, Piatti L, Greco C, Petronio S, Loi B, Lioy E, Benassi A, Patti A, Gaspardone A, Capodanno D, Biondi-Zoccai GG, Sangiorgi G, I-BIGIS study group (2010) Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS). Am Heart J 160:535–542.e1PubMedCrossRef
19.
Zurück zum Zitat Biondi-Zoccai G, Romagnoli E, Agostoni P, Capodanno D, Castagno D, D’ascenzo F, Sangiorgi G, Modena MG (2011) Are propensity scores really superior to standard multivariable analysis? Contemp Clin Trials. doi:10.1016/j.cct.2011.05.006 Biondi-Zoccai G, Romagnoli E, Agostoni P, Capodanno D, Castagno D, D’ascenzo F, Sangiorgi G, Modena MG (2011) Are propensity scores really superior to standard multivariable analysis? Contemp Clin Trials. doi:10.​1016/​j.​cct.​2011.​05.​006
20.
Zurück zum Zitat Albiero R, Rau T, Schlüter M, Di Mario C, Reimers B, Mathey DG, Tobis JM, Schofer J, Colombo A (1997) Comparison of immediate and intermediate-term results of intravascular ultrasound versus angiography-guided Palmaz-Schatz stent implantation in matched lesions. Circulation 96:2997–3005PubMed Albiero R, Rau T, Schlüter M, Di Mario C, Reimers B, Mathey DG, Tobis JM, Schofer J, Colombo A (1997) Comparison of immediate and intermediate-term results of intravascular ultrasound versus angiography-guided Palmaz-Schatz stent implantation in matched lesions. Circulation 96:2997–3005PubMed
21.
Zurück zum Zitat Jakabcin J, Spacek R, Bystron M, Kvasnák M, Jager J, Veselka J, Kala P, Cervinka P (2010) Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS. Catheter Cardiovasc Interv 75:578–583PubMed Jakabcin J, Spacek R, Bystron M, Kvasnák M, Jager J, Veselka J, Kala P, Cervinka P (2010) Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS. Catheter Cardiovasc Interv 75:578–583PubMed
22.
Zurück zum Zitat Biondi-Zoccai GG, Chieffo A, Agostoni P, Colombo A (2005) Applying intravascular ultrasound to optimize the placement of coronary drug-eluting stents. Minerva Cardioangiol 53:165–176PubMed Biondi-Zoccai GG, Chieffo A, Agostoni P, Colombo A (2005) Applying intravascular ultrasound to optimize the placement of coronary drug-eluting stents. Minerva Cardioangiol 53:165–176PubMed
23.
Zurück zum Zitat Kim WH, Lee BK, Lee S, Shim JM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK (2010) Serial changes of minimal stent malapposition not detected by intravascular ultrasound: follow-up optical coherence tomography study. Clin Res Cardiol 99:639–644PubMedCrossRef Kim WH, Lee BK, Lee S, Shim JM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK (2010) Serial changes of minimal stent malapposition not detected by intravascular ultrasound: follow-up optical coherence tomography study. Clin Res Cardiol 99:639–644PubMedCrossRef
24.
Zurück zum Zitat Biondi-Zoccai G, Sheiban I, Moretti C, Palmerini T, Marzocchi A, Capodanno D, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli AL, Briguori C, Vignali L, Pede F, Ramondo A, Medda M, de Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, Barlocco F, de Servi S (2011) Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. Clin Res Cardiol 100:403–411PubMedCrossRef Biondi-Zoccai G, Sheiban I, Moretti C, Palmerini T, Marzocchi A, Capodanno D, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli AL, Briguori C, Vignali L, Pede F, Ramondo A, Medda M, de Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, Barlocco F, de Servi S (2011) Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. Clin Res Cardiol 100:403–411PubMedCrossRef
25.
Zurück zum Zitat Zahn R, Hamm CW, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Pfannebecker T, Senges J (2010) Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher Stent Registry. Clin Res Cardiol 99:99–106PubMedCrossRef Zahn R, Hamm CW, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Pfannebecker T, Senges J (2010) Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher Stent Registry. Clin Res Cardiol 99:99–106PubMedCrossRef
Metadaten
Titel
Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry
verfasst von
Giuseppe Biondi-Zoccai
Imad Sheiban
Enrico Romagnoli
Stefano De Servi
Corrado Tamburino
Antonio Colombo
Francesco Burzotta
Patrizia Presbitero
Leonardo Bolognese
Leonardo Paloscia
Paolo Rubino
Gennaro Sardella
Carlo Briguori
Luigi Niccoli
Gianfranco Franco
Domenico Di Girolamo
Luigi Piatti
Cesare Greco
Davide Capodanno
Giuseppe Sangiorgi
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 11/2011
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-011-0336-x

Weitere Artikel der Ausgabe 11/2011

Clinical Research in Cardiology 11/2011 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.